BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27865273)

  • 1. Genetics of Pancreatic Cancer and Its Implications on Therapy.
    Tatarian T; Winter JM
    Surg Clin North Am; 2016 Dec; 96(6):1207-1221. PubMed ID: 27865273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine.
    Knudsen ES; O'Reilly EM; Brody JR; Witkiewicz AK
    Gastroenterology; 2016 Jan; 150(1):48-63. PubMed ID: 26385075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic roadmap of pancreatic cancer: still evolving.
    Notta F; Hahn SA; Real FX
    Gut; 2017 Dec; 66(12):2170-2178. PubMed ID: 28993418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular landscape of pancreatic cancer: implications for current clinical trials.
    Heestand GM; Kurzrock R
    Oncotarget; 2015 Mar; 6(7):4553-61. PubMed ID: 25714017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
    Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using next-generation sequencing to determine potential molecularly guided therapy options for patients with resectable pancreatic adenocarcinoma.
    Wright GP; Chesla DW; Chung MH
    Am J Surg; 2016 Mar; 211(3):506-11. PubMed ID: 26754455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of pancreatic cancer.
    Maitra A; Kern SE; Hruban RH
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):211-26. PubMed ID: 16549325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of pancreatic cancer.
    Saiki Y; Horii A
    Pathol Int; 2014 Jan; 64(1):10-9. PubMed ID: 24471965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic progression of pancreatic cancer.
    Cowan RW; Maitra A
    Cancer J; 2014; 20(1):80-4. PubMed ID: 24445769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductal pancreatic cancer in humans and mice.
    Tuveson DA; Hingorani SR
    Cold Spring Harb Symp Quant Biol; 2005; 70():65-72. PubMed ID: 16869739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of pancreatic neoplasms and their morphologic correlates: an update on recent advances and potential diagnostic applications.
    Reid MD; Saka B; Balci S; Goldblum AS; Adsay NV
    Am J Clin Pathol; 2014 Feb; 141(2):168-80. PubMed ID: 24436263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.
    Notta F; Chan-Seng-Yue M; Lemire M; Li Y; Wilson GW; Connor AA; Denroche RE; Liang SB; Brown AM; Kim JC; Wang T; Simpson JT; Beck T; Borgida A; Buchner N; Chadwick D; Hafezi-Bakhtiari S; Dick JE; Heisler L; Hollingsworth MA; Ibrahimov E; Jang GH; Johns J; Jorgensen LG; Law C; Ludkovski O; Lungu I; Ng K; Pasternack D; Petersen GM; Shlush LI; Timms L; Tsao MS; Wilson JM; Yung CK; Zogopoulos G; Bartlett JM; Alexandrov LB; Real FX; Cleary SP; Roehrl MH; McPherson JD; Stein LD; Hudson TJ; Campbell PJ; Gallinger S
    Nature; 2016 Oct; 538(7625):378-382. PubMed ID: 27732578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological Implications of Wingless/int1 (WNT) Signaling Pathway in Pancreatic Ductal Adenocarcinoma.
    Nakamoto M; Hisaoka M
    J UOEH; 2016 Mar; 38(1):1-8. PubMed ID: 26972939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic signatures of pancreatic adenosquamous carcinoma (PASC).
    Fang Y; Su Z; Xie J; Xue R; Ma Q; Li Y; Zhao Y; Song Z; Lu X; Li H; Peng C; Bai F; Shen B
    J Pathol; 2017 Oct; 243(2):155-159. PubMed ID: 28722109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer.
    Bazzichetto C; Conciatori F; Luchini C; Simionato F; Santoro R; Vaccaro V; Corbo V; Falcone I; Ferretti G; Cognetti F; Melisi D; Scarpa A; Ciuffreda L; Milella M
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy developments for pancreatic cancer.
    Bhattacharyya M; Lemoine NR
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):285-98. PubMed ID: 16549328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas.
    Hidalgo M; Von Hoff DD
    Clin Cancer Res; 2012 Aug; 18(16):4249-56. PubMed ID: 22896691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
    Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
    Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized therapy for pancreatic cancer: Do we need better targets, arrows, or both?
    O'Hayer KM; Brody JR
    Discov Med; 2016 Feb; 21(114):117-23. PubMed ID: 27011047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Novel Treatment Strategy for Pancreatic Cancer Based on Gene Profiles].
    Hayashi H; Nishihara H
    Gan To Kagaku Ryoho; 2016 Nov; 43(11):1326-1331. PubMed ID: 27899773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.